These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23669387)

  • 21. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
    Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN
    J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough invasive candidiasis in patients on micafungin.
    Pfeiffer CD; Garcia-Effron G; Zaas AK; Perfect JR; Perlin DS; Alexander BD
    J Clin Microbiol; 2010 Jul; 48(7):2373-80. PubMed ID: 20421445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose escalation studies with caspofungin against Candida glabrata.
    Domán M; Kovács R; Perlin DS; Kardos G; Gesztelyi R; Juhász B; Bozó A; Majoros L
    J Med Microbiol; 2015 Sep; 64(9):998-1007. PubMed ID: 26296340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
    Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
    Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [No Abstract]   [Full Text] [Related]  

  • 26. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
    Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
    Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.
    Arendrup MC; Park S; Brown S; Pfaller M; Perlin DS
    Antimicrob Agents Chemother; 2011 May; 55(5):1891-5. PubMed ID: 21357293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Echinocandin-Resistant
    Bordallo-Cardona MÁ; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
    J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
    Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
    J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin.
    Amanloo S; Shams-Ghahfarokhi M; Ghahri M; Razzaghi-Abyaneh M
    Rev Iberoam Micol; 2018; 35(2):88-91. PubMed ID: 29685375
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China.
    Li Y; Hou X; Li R; Liao K; Ma L; Wang X; Ji P; Kong H; Xia Y; Ding H; Kang W; Zhang G; Li J; Xiao M; Li Y; Xu Y
    BMC Microbiol; 2023 Nov; 23(1):341. PubMed ID: 37974063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
    Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan.
    Memon S; Ghanchi NK; Zafar U; Farooqi J; Zaka S; Jabeen K
    Mycoses; 2023 Jan; 66(1):52-58. PubMed ID: 36106428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
    Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
    PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
    Desnos-Ollivier M; Bretagne S; Lortholary O; Dromer F;
    Antimicrob Agents Chemother; 2022 May; 66(5):e0172521. PubMed ID: 35412354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.
    Healey KR; Katiyar SK; Castanheira M; Pfaller MA; Edlind TD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3947-9. PubMed ID: 21628537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.